Enhanced post-licensure safety surveillance of a new recombinant acellular pertussis vaccine licensed as a monovalent (aP, Pertagen?) and tetanus, reduced-dose diphtheria combination (TdaP, Boostagen?) vaccine for immunization of adolescents and adults in Thailand